All Publications

Real-world study of patients with germline BRCA1/2-mutated human epidermal growth factor receptor 2‒Negative advanced breast cancer: Patient demographics, treatment patterns, adverse events, and physician-reported satisfaction in the United States, Europe, and Israel

12-1-2022

Article

Additional authors and institutional affiliations

Breast (2022) 66:236-244

This document is currently not available here.

COinS